ATE191472T1 - Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen - Google Patents
Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE191472T1 ATE191472T1 AT96921482T AT96921482T ATE191472T1 AT E191472 T1 ATE191472 T1 AT E191472T1 AT 96921482 T AT96921482 T AT 96921482T AT 96921482 T AT96921482 T AT 96921482T AT E191472 T1 ATE191472 T1 AT E191472T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing same
- metalloprotease inhibitors
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48425595A | 1995-06-07 | 1995-06-07 | |
| US08/549,345 US5831004A (en) | 1994-10-27 | 1995-10-27 | Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use |
| PCT/US1996/009932 WO1996040738A1 (en) | 1995-06-07 | 1996-06-06 | Novel inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE191472T1 true ATE191472T1 (de) | 2000-04-15 |
Family
ID=27047928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96921482T ATE191472T1 (de) | 1995-06-07 | 1996-06-06 | Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US5831004A (de) |
| EP (1) | EP0832100B1 (de) |
| AT (1) | ATE191472T1 (de) |
| AU (1) | AU700239B2 (de) |
| CA (1) | CA2222923A1 (de) |
| DE (1) | DE69607615T2 (de) |
| WO (1) | WO1996040738A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5831004A (en) * | 1994-10-27 | 1998-11-03 | Affymax Technologies N.V. | Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use |
| US6811995B1 (en) * | 1996-04-26 | 2004-11-02 | Children's Medical Center Corporation | Non-invasive enzyme screen for cancer |
| TW424083B (en) * | 1996-07-10 | 2001-03-01 | American Cyanamid Co | Mercaptoketones and mercaptoalcohols and a process for their prepartation |
| US5852213A (en) * | 1996-07-10 | 1998-12-22 | American Cyanamid Company | Mercaptoketones and mercaptoalcohols and a process for their preparation |
| US6281245B1 (en) * | 1996-10-28 | 2001-08-28 | Versicor, Inc. | Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof |
| WO1998018754A1 (en) | 1996-10-28 | 1998-05-07 | Versicor, Inc. | Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof |
| US6034136A (en) | 1997-03-20 | 2000-03-07 | Novartis Ag | Certain cyclic thio substituted acylaminoacid amide derivatives |
| US6204279B1 (en) * | 1998-06-03 | 2001-03-20 | Microcide Pharmaceuticals, Inc. | Peptidomimetic efflux pump inhibitors |
| AU2337599A (en) * | 1998-01-23 | 1999-08-09 | Microcide Pharmaceuticals, Inc. | Efflux pump inhibitors |
| HRP20000904A2 (en) * | 1998-07-06 | 2001-12-31 | Janssen Pharmaceutica Nv | Farnesyl protein transferase inhibitors for treating arthropathies |
| US20040122011A1 (en) * | 1998-12-23 | 2004-06-24 | Pharmacia Corporation | Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy |
| US6713309B1 (en) | 1999-07-30 | 2004-03-30 | Large Scale Proteomics Corporation | Microarrays and their manufacture |
| US7179638B2 (en) | 1999-07-30 | 2007-02-20 | Large Scale Biology Corporation | Microarrays and their manufacture by slicing |
| US6806331B1 (en) * | 2000-04-20 | 2004-10-19 | Soken Chemical And Engineering Co., Ltd. | Process for bulk polymerization using a catalyst |
| US7186693B2 (en) * | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
| US7364719B2 (en) * | 2002-10-04 | 2008-04-29 | The United States Of America As Represented By The Department Of Health And Human Services | Vasoregulating compounds and methods of their use |
| AU2003295422B2 (en) * | 2002-11-07 | 2009-01-29 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | A new target for angiogenesis and anti-angiogenesis therapy |
| US7189700B2 (en) * | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
| DK2041181T3 (da) * | 2006-06-08 | 2011-08-29 | Helmholtz Zentrum Muenchen | Specifikke proteaseinhibitorer og deres anvendelse i cancerterapi |
| WO2009121168A1 (en) * | 2008-04-01 | 2009-10-08 | Biopharmacopae Design International Inc. | Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection |
| WO2017117130A1 (en) | 2015-12-28 | 2017-07-06 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for inhibiting human immunodeficiency virus (hiv) release from infected cells |
| SI3464336T1 (sl) | 2016-06-01 | 2022-06-30 | Athira Pharma, Inc. | Spojine |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4091178A (en) * | 1977-10-25 | 1980-04-24 | Merck & Co Inc | Substituted mercapto acid amides |
| US4235885A (en) * | 1979-06-25 | 1980-11-25 | E. R. Squibb & Sons, Inc. | Inhibitors of mammalian collagenase |
| JPS5677296A (en) * | 1979-11-29 | 1981-06-25 | Ajinomoto Co Inc | Tryptophane derivative and its preparation |
| US4327111A (en) * | 1980-07-14 | 1982-04-27 | E. R. Squibb & Sons, Inc. | N-Substituted mercaptoacyl pripionamides |
| US4424354A (en) * | 1981-06-12 | 1984-01-03 | E. R. Squibb & Sons, Inc. | Inhibitors of mammalian collagenase |
| US4371466A (en) * | 1981-10-07 | 1983-02-01 | American Home Products Corporation | Mammalian collagenase inhibitors |
| GB8311286D0 (en) * | 1983-04-26 | 1983-06-02 | Searle & Co | Carboxyalkyl peptide derivatives |
| US4568666A (en) * | 1984-10-18 | 1986-02-04 | G. D. Searle & Co. | Carboxylalkyl peptide derivatives |
| US4826958A (en) * | 1984-12-14 | 1989-05-02 | Abbott Laboratories | Renin inhibiting compounds |
| US4595700A (en) * | 1984-12-21 | 1986-06-17 | G. D. Searle & Co. | Thiol based collagenase inhibitors |
| US4681966A (en) * | 1985-02-21 | 1987-07-21 | G. D. Searle & Co. | Intermediate for thiol based collagenase inhibitors |
| US4826815A (en) * | 1985-05-17 | 1989-05-02 | Abbott Laboratories | Renin inhibiting compounds |
| US4599361A (en) * | 1985-09-10 | 1986-07-08 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
| US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
| US4720486A (en) * | 1985-10-18 | 1988-01-19 | Monsanto Company | Method of inhibiting vertebrate collagenase activity using peptide hydroxamic acid derivatives |
| JPS62114689A (ja) * | 1985-11-12 | 1987-05-26 | 新日本製鐵株式会社 | フルイ装置 |
| EP0258289A4 (en) * | 1986-01-16 | 1991-01-02 | Joseph Dellaria | Peptide analogs |
| US4857507A (en) * | 1986-04-11 | 1989-08-15 | Abbott Laboratories | Angiotensinogen analogs |
| US4771038A (en) * | 1986-01-21 | 1988-09-13 | Ici Americas Inc. | Hydroxamic acids |
| DK77487A (da) * | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
| ZW23187A1 (en) * | 1986-12-15 | 1988-06-29 | Hoffmann La Roche | Phosphinic acid derivatives |
| NZ223037A (en) * | 1986-12-24 | 1991-04-26 | Beecham Group Plc | Thiol-carboxylic acid derivatives and pharmaceutical compositions thereof |
| FR2609289B1 (fr) * | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes |
| PT86864B (pt) * | 1987-02-27 | 1992-05-29 | Gist Brocades Nv | Processo para clonagem molecular e expressao de genes que codificam para enzimas proteoliticas |
| DE3889726T2 (de) * | 1987-03-17 | 1994-10-13 | Res Corp Technologies Inc | Synthetische inhibitoren von säugetier-collagenase. |
| US4891356A (en) * | 1987-07-15 | 1990-01-02 | Brigham & Women's Hospital | Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| GB8726714D0 (en) * | 1987-11-14 | 1987-12-16 | Beecham Group Plc | Compounds |
| JPH01146896A (ja) * | 1987-12-04 | 1989-06-08 | Fuji Yakuhin Kogyo Kk | 新規なペプチジルヒドロキサム酸誘導体 |
| JP2573006B2 (ja) * | 1987-12-17 | 1997-01-16 | 富士薬品工業株式会社 | 新規なヒドロキサム酸誘導体 |
| GB8729804D0 (en) * | 1987-12-22 | 1988-02-03 | Beecham Group Plc | Novel compounds |
| EP0345104B1 (de) * | 1988-06-02 | 1995-11-02 | Merrell Dow Pharmaceuticals Inc. | Alpha-glukosidase-Inhibitoren |
| GB8814813D0 (en) * | 1988-06-22 | 1988-07-27 | Beecham Group Plc | Novel compounds |
| WO1990005141A1 (en) * | 1988-11-10 | 1990-05-17 | Australian Commercial Research & Development Limited | Amino acid and peptide inhibitors of human leukocytic elastase and collagenase |
| GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| GB8827308D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| EP0401963A1 (de) * | 1989-04-13 | 1990-12-12 | Beecham Group p.l.c. | Phosphonopeptide mit kollagenase-inhibitierender Wirkung |
| WO1990014363A1 (en) * | 1989-05-19 | 1990-11-29 | Amgen Inc. | Metalloproteinase inhibitor |
| GB8919251D0 (en) * | 1989-08-24 | 1989-10-04 | British Bio Technology | Compounds |
| GB8921326D0 (en) * | 1989-09-21 | 1989-11-08 | Beecham Group Plc | Novel treatment |
| WO1991012287A1 (en) * | 1990-02-13 | 1991-08-22 | Doyle Earl N | Process for producing n=c=o foams and the controlled pre- and post-expansion thereof |
| GB9008065D0 (en) * | 1990-04-10 | 1990-06-06 | Beecham Group Plc | Novel compounds |
| GB9008078D0 (en) * | 1990-04-10 | 1990-06-06 | Beecham Group Plc | Novel compounds |
| US5268384A (en) * | 1990-11-21 | 1993-12-07 | Galardy Richard E | Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| JPH05503719A (ja) * | 1990-12-03 | 1993-06-17 | セルテック リミテッド | ペプチジル誘導体 |
| WO1992022523A2 (en) * | 1991-06-14 | 1992-12-23 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
| US5256657A (en) * | 1991-08-19 | 1993-10-26 | Sterling Winthrop, Inc. | Succinamide derivative matrix-metalloprotease inhibitors |
| GB9122859D0 (en) * | 1991-10-28 | 1991-12-11 | Smithkline Beecham Plc | Novel compounds |
| GB9200826D0 (en) * | 1992-01-15 | 1992-03-11 | Celltech Ltd | Peptidyl derivatives |
| WO1993018173A2 (en) * | 1992-03-11 | 1993-09-16 | Xenova Limited | Cd4 binding agents and inhibitors of collagenase and protein kinase c |
| US5324634A (en) * | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
| EP0639982A1 (de) * | 1992-05-01 | 1995-03-01 | British Biotech Pharmaceuticals Limited | Verwendung von mmp hemmer |
| EP0642353A1 (de) * | 1992-05-14 | 1995-03-15 | Oncologix, Inc. | Behandlung des vaskularen permeabilitätssyndroms und der kollagenase induzierten krankheit durch administrieren von inhibitoren der matrix-metalloproteinase(20.01.94) |
| GB9211706D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
| GB9211707D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
| AU666727B2 (en) * | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
| WO1994007481A1 (en) * | 1992-10-02 | 1994-04-14 | Merck & Co., Inc. | N-(mercaptoacyl)peptidyl derivatives as antidegenerative agents |
| US5594106A (en) * | 1993-08-23 | 1997-01-14 | Immunex Corporation | Inhibitors of TNF-α secretion |
| GB9318653D0 (en) * | 1993-09-08 | 1993-10-27 | Raychem Sa Nv | Optical fibre organizer |
| UA48121C2 (uk) * | 1993-11-04 | 2002-08-15 | Сінтекс (С.Ш.А.) Інк. | Інгібітори матричних металопротеаз і фармацетична композиція на їх основі |
| US5831004A (en) * | 1994-10-27 | 1998-11-03 | Affymax Technologies N.V. | Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use |
| US5840698A (en) * | 1994-10-27 | 1998-11-24 | Affymax Technologies N.V. | Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use |
-
1995
- 1995-10-27 US US08/549,345 patent/US5831004A/en not_active Expired - Fee Related
-
1996
- 1996-06-06 AU AU62699/96A patent/AU700239B2/en not_active Ceased
- 1996-06-06 EP EP96921482A patent/EP0832100B1/de not_active Expired - Lifetime
- 1996-06-06 CA CA002222923A patent/CA2222923A1/en not_active Abandoned
- 1996-06-06 AT AT96921482T patent/ATE191472T1/de active
- 1996-06-06 DE DE69607615T patent/DE69607615T2/de not_active Expired - Fee Related
- 1996-06-06 WO PCT/US1996/009932 patent/WO1996040738A1/en not_active Ceased
-
1998
- 1998-05-19 US US09/081,466 patent/US5929278A/en not_active Expired - Fee Related
-
1999
- 1999-03-17 US US09/271,801 patent/US6307101B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5929278A (en) | 1999-07-27 |
| EP0832100B1 (de) | 2000-04-05 |
| WO1996040738A1 (en) | 1996-12-19 |
| US6307101B1 (en) | 2001-10-23 |
| US5831004A (en) | 1998-11-03 |
| AU6269996A (en) | 1996-12-30 |
| DE69607615D1 (de) | 2000-05-11 |
| CA2222923A1 (en) | 1996-12-19 |
| EP0832100A4 (de) | 1998-09-02 |
| EP0832100A1 (de) | 1998-04-01 |
| DE69607615T2 (de) | 2000-12-14 |
| AU700239B2 (en) | 1998-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69607615D1 (de) | Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen | |
| GB8919251D0 (en) | Compounds | |
| DE60117043D1 (de) | Behandlung von mukositis | |
| DE69625691D1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
| DE69627467D1 (de) | Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten | |
| DE60239343D1 (de) | Mittel zur behandlung von erkrankungen, die mit knochenschwund einhergehen, mit ep4-agonist als wirkstoff | |
| DE69929996D1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
| DE69736441D1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
| ATE531688T1 (de) | Verbindungen zur modulation des rage-rezeptors | |
| DE60212613D1 (de) | Doxycyclin zur behandlung von akne | |
| DK1059934T3 (da) | Matrixproteinpræparater til sårheling | |
| DE69932939D1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
| BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
| BR0114344A (pt) | Retinóides para o tratamento de enfisema | |
| BR0308957A (pt) | Composto, composição farmacêutica, método para o tratamento de uma inflamação ou de uma desordem associada a uma inflamação em um paciente, uso dos compostos e processo para sua preparação | |
| ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| DE69620691D1 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
| ATE357912T1 (de) | Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten | |
| EP1488808A4 (de) | Mittel zur behandlung von glomerulären erkrankungen | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| DK0821969T3 (da) | Medicinsk sammensætning omfattende TCF-II | |
| RU95110774A (ru) | Олигонуклеотиды, терапевтические композиции, применение композиций | |
| ID21369A (id) | Komposisi farmasi untuk penyembuhan penyakit yang disebabkan oleh virus | |
| SE0004827D0 (sv) | Therapeutic compounds |